MTOR and hereditary clear cell renal cell carcinoma: For example, we and others have shown that mTOR inhibition attenuates chemotherapy-mediated cell death in colon and renal cell carcinoma cell lines [24, 39], and in certain genetic contexts, such as loss of TSC1/2 [18] or REDD1 [17].